Matches in Nanopublications for { ?s ?p "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780196.RARcMcheoSFVSQtgY41pEEc6D8OS1zn4DyE2dSx1uIVfU130_provenance.
- assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779851.RAtImnu3fmNI9kNYdOdNDkRi-TSG7NqR8qbThw1Nskwh8130_provenance.
- NP1159940.RAh-OPib0mlxfqPVZdMZjZIlac0Tdd8jD0JVSY4bacgkI130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1159940.RAh-OPib0mlxfqPVZdMZjZIlac0Tdd8jD0JVSY4bacgkI130_provenance.
- NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_assertion description "[Results from the current meta-analysis indicate that XRCC1 Arg399Gln polymorphism may be associated with poor clinical outcomes in GC patients treated with oxaliplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1159938.RAG_n4UFVaVWHHEV0_Y_P7NZI9ursAV_kA76rUuuKh2kA130_provenance.